4-[4-(5,5-Dimethyl-[1,3,2]dioxaborinan-2-yl)-phenyl]-butyric acid → (3-Cyanophenyl)carbamic acid 2-[4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-phenyl]ethyl ester
Reaction equation
[CH3:1][C:2]1([CH3:20])[CH2:7][O:6][B:5]([C:8]2[CH:13]=[CH:12][C:11]([CH2:14][CH2:15]CC(O)=O)=[CH:10][CH:9]=2)[O:4][CH2:3]1.BrC1C=CC(CC[O:30][C:31](=[O:41])[NH:32][C:33]2[CH:38]=[CH:37][CH:36]=[C:35]([C:39]#[N:40])[CH:34]=2)=CC=1>>[CH3:20][C:2]1([CH3:1])[CH2:3][O:4][B:5]([C:8]2[CH:9]=[CH:10][C:11]([CH2:14][CH2:15][O:41][C:31](=[O:30])[NH:32][C:33]3[CH:38]=[CH:37][CH:36]=[C:35]([C:39]#[N:40])[CH:34]=3)=[CH:12][CH:13]=2)[O:6][CH2:7]1Participants
3
Procedure
Using a procedure analogous to that used to prepare 2A, 11A (516 mg, 1.50 mmol) was reacted with 5,5′,5′-tetramethyl-[2,2′]bi[[1,3,2]dioxaborinanyl] to give 11B (434 mg, 76%). This crude material was taken on to the next step.
Sources & evidence
- ORD record
- ord-5a0817db0c864938b1ebd96e8c03336b
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07592331B2
Reaction notes
Loading…